Intracoronary Stenting and Angiographic Restenosis: Promote Endothelial Cells With Estradiol - ISAR-PEACE – Presented at ACC 2007


The goal of the trial was to evaluate percutaneous coronary intervention (PCI) use of a polymer-free, estradiol plus rapamycin-eluting stent (ERES) compared with a polymer-free, rapamycin-eluting stent (RES) among patients with de novo native coronary artery disease.